Clinical Trials Directory

Trials / Completed

CompletedNCT05205525

Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)

Aggressive Versus Restrictive Initiation of Antimicrobial Treatment in Critically Ill Patients With Suspected Ventilator Acquired Pneumonia Without Severity : a Before and After Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This retro-prospective monocentric observational study compare the impact of the implementation of a restrictive (delayed) versus aggressive (immediate) antibiotic strategy for Ventilator Acquired Pneumonia suspicion without severity symptoms.

Detailed description

Ventilator acquired pneumonia (VAP) is the leading cause of nosocomial infection in intensive care patients, and has been associated with increased antibiotic consumption, increased morbidity and mortality. VAP diagnosis is difficult due to subjective or non-specific criteria. Delaying antibiotic treatment for VAP suspicion without severity symptoms raises question since the probability of VAP diagnosis, as well as the risk of delaying treatment, is very uncertain. It may nonetheless limit the environmental impact of antibiotic use which is a public health concern. We compared antibiotic sparing and patient outcome, before and after the implementation of a restrictive (delayed) antibiotic strategy versus an aggressive (immediate) antibiotic strategy in VAP suspicion without severity symptoms.

Conditions

Interventions

TypeNameDescription
OTHERRestrictive antibiotic strategyImplementation of a restrictive (delayed) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.
OTHERAggressive antibiotic strategyImplementation of an aggressive (immediate) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.

Timeline

Start date
2022-01-06
Primary completion
2023-01-28
Completion
2023-01-28
First posted
2022-01-25
Last updated
2023-03-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05205525. Inclusion in this directory is not an endorsement.